Total Visits

Views
Predictive value of interim 18F-FDG-PET/CT for event-free survival in patients with diffuse large B-cell lymphoma homogenously treated in a phase II trial with six cycles of R-CHOP-14 plus pegfilgrastim as first-line treatment42

Select a period of time:

Views

Views
January 20251
February 20252
March 202515
April 20252
May 20250
June 20252
July 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore17
United States4
Spain1
 

Top cities views

Views
Buffalo2
Council Bluffs1